Hospital Acquired Infections (HAI) Diagnostics Market Report

Global and Region Hospital Acquired Infections (HAI) Diagnostics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：142
  • REPORT CODE：GMM953555
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Hospital Acquired Infections (HAI) Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Hospital Acquired Infections (HAI) Diagnosticsmarket, defines the market attractiveness level of Hospital Acquired Infections (HAI) Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Hospital Acquired Infections (HAI) Diagnostics industry, describes the types of Hospital Acquired Infections (HAI) Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hospital Acquired Infections (HAI) Diagnostics market and the development prospects and opportunities of Hospital Acquired Infections (HAI) Diagnostics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hospital Acquired Infections (HAI) Diagnostics market in Chapter 13.

    By Player:

    • BioMérieux

    • Siemens Healthcare

    • Abbott Laboratories

    • Roche AG

    By Type:

    • Molecular Diagnostics Tests

    • Other In-vitro Diagnostic Tests

    By End-User:

    • Bloodstream Infections (BSI)

    • Urinary Tract Infections (UTI)

    • Surgical Site Infections (SSI)

    • Pneumonia

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Hospital Acquired Infections (HAI) Diagnostics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Hospital Acquired Infections (HAI) Diagnostics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Hospital Acquired Infections (HAI) Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Hospital Acquired Infections (HAI) Diagnostics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Hospital Acquired Infections (HAI) Diagnostics Market Analysis and Outlook to 2022

    • 7.1 Global Hospital Acquired Infections (HAI) Diagnostics Consumption (2017-2022)

    • 7.2 United States Hospital Acquired Infections (HAI) Diagnostics Consumption (2017-2022)

    • 7.3 Europe Hospital Acquired Infections (HAI) Diagnostics Consumption (2017-2022)

    • 7.4 China Hospital Acquired Infections (HAI) Diagnostics Consumption (2017-2022)

    • 7.5 Japan Hospital Acquired Infections (HAI) Diagnostics Consumption (2017-2022)

    • 7.6 India Hospital Acquired Infections (HAI) Diagnostics Consumption (2017-2022)

    • 7.7 South Korea Hospital Acquired Infections (HAI) Diagnostics Consumption (2017-2022)

    8 Region and Country-wise Hospital Acquired Infections (HAI) Diagnostics Market Analysis and Outlook to 2028

    • 8.1 Global Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast (2022-2028)

    • 8.2 United States Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast (2022-2028)

    • 8.3 Europe Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast (2022-2028)

    • 8.4 China Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast (2022-2028)

    • 8.5 Japan Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast (2022-2028)

    • 8.6 India Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast (2022-2028)

    • 8.7 South Korea Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast (2022-2028)

    9 Global Hospital Acquired Infections (HAI) Diagnostics Market Outlook by Types and Applications to 2022

    • 9.1 Global Hospital Acquired Infections (HAI) Diagnostics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Molecular Diagnostics Tests Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Other In-vitro Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • 9.2 Global Hospital Acquired Infections (HAI) Diagnostics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Bloodstream Infections (BSI) Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Urinary Tract Infections (UTI) Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Surgical Site Infections (SSI) Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Pneumonia Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Hospital Acquired Infections (HAI) Diagnostics Market Outlook by Types and Applications to 2028

    • 10.1 Global Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Molecular Diagnostics Tests Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Other In-vitro Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Bloodstream Infections (BSI) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Urinary Tract Infections (UTI) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Surgical Site Infections (SSI) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Pneumonia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Hospital Acquired Infections (HAI) Diagnostics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Hospital Acquired Infections (HAI) Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Hospital Acquired Infections (HAI) Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Hospital Acquired Infections (HAI) Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Hospital Acquired Infections (HAI) Diagnostics Market Competitive Analysis

    • 14.1 BioMérieux

      • 14.1.1 BioMérieux Company Details

      • 14.1.2 BioMérieux Hospital Acquired Infections (HAI) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 BioMérieux Hospital Acquired Infections (HAI) Diagnostics Product and Service

    • 14.2 Siemens Healthcare

      • 14.2.1 Siemens Healthcare Company Details

      • 14.2.2 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Product and Service

    • 14.3 Abbott Laboratories

      • 14.3.1 Abbott Laboratories Company Details

      • 14.3.2 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Product and Service

    • 14.4 Roche AG

      • 14.4.1 Roche AG Company Details

      • 14.4.2 Roche AG Hospital Acquired Infections (HAI) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Hospital Acquired Infections (HAI) Diagnostics

    • Figure Hospital Acquired Infections (HAI) Diagnostics Picture

    • Table Global Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hospital Acquired Infections (HAI) Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hospital Acquired Infections (HAI) Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Hospital Acquired Infections (HAI) Diagnostics Consumption by Country (2017-2022)

    • Figure United States Hospital Acquired Infections (HAI) Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Europe Hospital Acquired Infections (HAI) Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure China Hospital Acquired Infections (HAI) Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Japan Hospital Acquired Infections (HAI) Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure India Hospital Acquired Infections (HAI) Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Hospital Acquired Infections (HAI) Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure United States Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Hospital Acquired Infections (HAI) Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Molecular Diagnostics Tests Consumption and Growth Rate (2017-2022)

    • Figure Global Other In-vitro Diagnostic Tests Consumption and Growth Rate (2017-2022)

    • Figure Global Bloodstream Infections (BSI) Consumption and Growth Rate (2017-2022)

    • Figure Global Urinary Tract Infections (UTI) Consumption and Growth Rate (2017-2022)

    • Figure Global Surgical Site Infections (SSI) Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumonia Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Molecular Diagnostics Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other In-vitro Diagnostic Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bloodstream Infections (BSI) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Urinary Tract Infections (UTI) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surgical Site Infections (SSI) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumonia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Hospital Acquired Infections (HAI) Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Hospital Acquired Infections (HAI) Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    • Table BioMérieux (Foundation Year, Company Profile and etc.)

    • Table BioMérieux Hospital Acquired Infections (HAI) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMérieux Hospital Acquired Infections (HAI) Diagnostics Product and Service

    • Table Siemens Healthcare (Foundation Year, Company Profile and etc.)

    • Table Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Product and Service

    • Table Roche AG (Foundation Year, Company Profile and etc.)

    • Table Roche AG Hospital Acquired Infections (HAI) Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche AG Hospital Acquired Infections (HAI) Diagnostics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US